IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY

• 1. 一种基于aGVHD biomarker的一线糖皮质激素治疗反应预测模型 [P] . 中国专利： CN113990486A . 2022-01-28
• 2. 一种基于aGVHD biomarker的非复发死亡风险监测模型 [P] . 中国专利： CN114464320A . 2022-05-10
• 3. Immunological biomarkers for predicting clinical efficacy of cancer immunotherapy [P] . 日本专利： JP2020512530A . 2020-04-23

  机译： 免疫生物标志物，用于预测癌症免疫疗法的临床疗效

• 4. Immunological biomarkers predict clinical efficacy of cancer immunotherapy [P] . 日本专利： JP6664684B1 . 2020-03-13

  机译： 免疫生物标志物预测癌症免疫疗法的临床疗效

• 5. IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY [P] . 日本专利： JP2020073924A . 2020-05-14

  机译： 免疫生物标志物预测癌症免疫治疗的临床效果

• 1. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer:the expression of BCL-2,E-cadherin,Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors [J] . Joseph Nariculam, Mark Feneley, Alex Freeman, 亚洲男性学杂志（英文版） . 2009,第001期
• 2. Clinical predictive values of biomarker levels in non-small cell lung cancer [J] . Wenqing Wei 肿瘤学与转化医学（英文） . 2017,第006期
• 3. Clinical predictive values of biomarker levels in non-small cell lung cancer [J] . Wenqing Wei 中德临床肿瘤学杂志（英文版） . 2017,第006期
• 4. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy [J] . Mary L. Disis Cancer Immunology, Immunotherapy . 2011,第3期
• 5. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy [J] . DisisM.L. Cancer immunology, immunotherapy : . 2011,第3期
• 6. Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia [J] . Aptsiauri Natalia, Jewett Anahid, Hurwitz Arthur A., Cancer immunology, immunotherapy : . 2016,第7期
• 7. Selecting Biomarkers that Better Predicts Cancer Outcome by Functional Transformation of Clinical Variables [C] . Shang Gao, A. M. Elsheikh, Reda Alhajj, International conference on bioinformatics and computational biology . 2013
• 8. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001
• 9. Immunologic Biomarkers and Biomarkers for Immunotherapies in Gastrointestinal Cancer [O] . Benedikt Martin, Bruno Märkl 2019
• 10. Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations [O] . 2016
• 11. Immunotherapy of Prostate Cancer - Prostate Cancer Vaccine Clinical Trial [R] . Mincheff, M. 2004

• 1. Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges [J] . Anil Suri ,Nirmala Jagadish ,Shikha Saini . 世界胃肠肿瘤学杂志：英文版（电子版） . 2015,第12期
• 2. Predictive Models of Clinical Improvement in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Biomarkers [J] . Jeannette M. Olazagasti ,Cynthia S. Crowson ,Molly S. Hein . 风湿病与自身免疫疾病期刊（英文） . 2015,第3期
• 3. Clinical Significance of POU5F1P1 rs10505477 Polymorphism in Chinese Gastric Cancer Patients Receiving Cisplatin-Based Chemotherapy after Surgical Resection [C] . 沈丽丽 . 第八届中国肿瘤内科大会、第三届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2014年学术年会 . 2014
• 4. CDH2 and SPP1 expression as biomarkers of Brain Metastasis in Patients with Non Small-Cell Lung Cancer [A] . 木诗 . 2014